A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.
A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.
复制标题
糖尿病肾病的突破:内皮功能障碍的作用。
DOI:
10.1093/ndt/gfm380
复制
发表时间:
2007
期刊:
影响因子:
--
通讯作者:
Johnson,RichardJ
中科院分区:
文献类型:
--
作者:
Nakagawa,Takahiko;Segal,Mark;Croker,Byron;Johnson,RichardJ
Kanetsuna et al.[1] have published an important paper in the American Journal of Pathology, reporting that renal lesions resembling human diabetic nephropathy can be induced in mice made diabetic (with streptozotocin) which genetically lack endothelial nitric oxide synthase (eNOS). eNOS is a key enzyme in endothelial cells that produces nitric oxide (NO). In turn, NO has multiple functions in the vasculature, including acting as a vasodilator, anti-inflammatory, anti-thrombotic and anti-proliferative activities. In this study, diabetic eNOS knockout mice developed both renal functional (proteinuria, reduced glomerular filtration rate) and structural changes consistent with human diabetic nephropathy. Up to now, it has been difficult to develop in mice models of diabetic nephropathy that resemble human disease, so this article represents a breakthrough in the pathogenesis of diabetic nephropathy.